Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of thyroid diseases, raising awareness of the disease, and favorable reimbursement and funding policies. According to the Thyroid Disease: Assessment and Management Draft of the National Institute for Health and Care Excellence published in 2017, hypothyroidism was estimated to be prevalent in 27.2% of the total UK population. Such prevalence of thyroid disorders provides suitable backgrounds for the market to grow.
QYResearch Expected to register a CAGR of 3.5% during the forecast period of 2019 to 2025.

Market Analysis and Insights: Global Thyroid Disorder Market
The global Thyroid Disorder market size is projected to reach US$ 3132.5 million by 2027, from US$ 2625.9 million in 2020, at a CAGR of 2.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Thyroid Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Thyroid Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Thyroid Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Thyroid Disorder market.

Global Thyroid Disorder Scope and Market Size
Thyroid Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Thyroid Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hypothyroidism
Hyperthyroidism

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer Inc
Allergan
AbbVie Inc.
Merck KGaA
RLC Labs
GlaxoSmithKline Plc
Mylan